Dr Dana Chase describes how structural disparities and prior minimized care delay diagnosis and erode trust, requiring ...
Dr Dana Chase recalls early-career experiences and describes how revolutionary advances in surgery and personalized medicine ...
Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...
University of Iowa doctoral student Katie Colling is making progress in identifying hormones that are effective at combating uterine cancer.
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...
Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...
Ramez N. Eskander, MD, discusses the optimal use of lenvatinib/pembrolizumab in clinical practice for patients with ...
The endometrial cancer market space will experience significant growth during the forecast period of 2025--2034. The future is brighter for patients with endometrial cancer. Targeted agents and ...
For the first time in its 75-year history of analyzing cancer data, the survival rate for all cancers combined reached 70% ...
Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...
In this retrospective cohort study of a large population in Belgium, researchers aimed to examine endometrial cancer risk in patients with breast cancer who received tamoxifen.
Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback